Alvotech
Latest news
Investors
21 August 2025
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Investors
20 August 2025
Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia
Investors
13 August 2025